FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) from Sumitomo Pharma America, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Latuda (lurasidone)

Snippet

SUPPL AP for LATUDA (LURASIDONE HYDROCHLORIDE)